These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Place and use of Atrium in predelirium states]. Berton M J Med Bord; 1967 Jul; 144(7):1056-62. PubMed ID: 5619378 [No Abstract] [Full Text] [Related]
24. [Psychopharmacological therapy in alcoholic diseases]. Lundquist GA Nord Psykiatr Tidsskr; 1966; 20(5):370-9. PubMed ID: 5970306 [No Abstract] [Full Text] [Related]
26. [Therapeutic developments in chronic alcoholism. Treatment of dysthymic disturbances due to the deficiency syndrome in alcoholic subjects]. Madeddu A Minerva Med; 1967 Feb; 58(12):400-6. PubMed ID: 5335499 [No Abstract] [Full Text] [Related]
27. [On our experiences with Distraneurin in the treatment of delirium tremens]. Beier R; Herbst A Z Arztl Fortbild (Jena); 1969 Mar; 63(6):334-7. PubMed ID: 5784075 [No Abstract] [Full Text] [Related]
28. A multicentric evaluation of pimozide (Orap) in patients who usually would take tranquillizers. Deberdt R Acta Psychiatr Belg; 1974 Nov; 74(6):653-60. PubMed ID: 4468710 [No Abstract] [Full Text] [Related]
29. [The clinical picture and therapy of alcoholic psychoses in old age]. Entin GM Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):743-50. PubMed ID: 5456877 [No Abstract] [Full Text] [Related]
30. [Clinical aspects, differential diagnosis and treatment of atypical alcoholic psychoses]. Danielian KG Zh Eksp Klin Med; 1977; 17(1):105-12. PubMed ID: 888606 [No Abstract] [Full Text] [Related]
31. [Clinical signs and management of delirium tremens]. Athen D; Beckmann H Internist (Berl); 1981 Jan; 22(1):43-5. PubMed ID: 7009481 [No Abstract] [Full Text] [Related]
32. [The place of dipotassic clorazepate in the treatment of delirium tremens and agitation states]. Roche L; Cuche M; Robert D; Paliard P; Motin J Lyon Med; 1971 Jan; 225(2):147-8. PubMed ID: 5551018 [No Abstract] [Full Text] [Related]
33. [Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold]. Haase HJ; Frank T; Knaack M; Lehnhardt C; Richter-Peill H Nervenarzt; 1968 Jun; 39(6):275-9. PubMed ID: 5712433 [No Abstract] [Full Text] [Related]
34. The use of major tranquillisers. Linford-Rees W J R Coll Gen Pract; 1973 Jun; 23 Suppl 2(Suppl 2):42-8. PubMed ID: 4766233 [No Abstract] [Full Text] [Related]
35. [Study of the injectable form of dipotassic clorazepate in the psychiatric hospital]. Lambert PA; Bouchardy M J Med Lyon; 1971 May; 52(208):763-71. PubMed ID: 5138670 [No Abstract] [Full Text] [Related]
36. [Management of schizophrenic psychoses using low-potency neuroleptics]. Kemperdick KT; Nieling C; Steinig A Med Klin; 1967 Sep; 62(39):1512-5. PubMed ID: 5596490 [No Abstract] [Full Text] [Related]
37. [Basic reflections on the use of psychopharmacentic agents--pharmacological aspects]. Westermann KH; Schmidt J Z Arztl Fortbild (Jena); 1977 Apr; 71(8):396-8. PubMed ID: 878510 [No Abstract] [Full Text] [Related]
38. [Psychopharmacologic drugs in the treatment of alcoholics]. Roos BE Lakartidningen; 1974 Aug; 71(34):3073 passim. PubMed ID: 4410624 [No Abstract] [Full Text] [Related]
39. Treatment of delirium tremens. Hoagland RJ South Med J; 1966 Sep; 59(9):1041-5. PubMed ID: 5919770 [No Abstract] [Full Text] [Related]